FDA.reportPublic FDA data

caffeine / dihydroergocryptine

RxCUI
1233902
RxNorm name
caffeine / dihydroergocryptine
Term type
MIN
Status
Active
Updated
2026-10-29 06:01:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012012
Active start
012012
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
dihydroergocryptine3417

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcaffeine / dihydroergocryptine1NAMES
RxNorm Namecaffeine / dihydroergocryptine1NAMES
TTYMIN1ATTRIBUTES
RxCUI12339021CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD002219CarbamatesCHEMci_chemclassdihydroergocryptine
MEDRTD025443DihydroergocryptineCHEMhas_ingredientdihydroergocryptine
MEDRTD005663FuransCHEMci_chemclassdihydroergocryptine
MEDRTD019888NelfinavirCHEMci_chemclassdihydroergocryptine
MEDRTD019438RitonavirCHEMci_chemclassdihydroergocryptine
MEDRTD013449SulfonamidesCHEMci_chemclassdihydroergocryptine
MEDRTD000033Abortion, ThreatenedDISEASEci_withdihydroergocryptine
MEDRTD000788Angina Pectoris, VariantDISEASEmay_diagnosedihydroergocryptine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withdihydroergocryptine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD007022HypotensionDISEASEmay_treatdihydroergocryptine
MEDRTD008881Migraine DisordersDISEASEmay_preventdihydroergocryptine
MEDRTD010300Parkinson DiseaseDISEASEmay_treatdihydroergocryptine
MEDRTD006473Postpartum HemorrhageDISEASEmay_preventdihydroergocryptine
MEDRTD006473Postpartum HemorrhageDISEASEmay_treatdihydroergocryptine
MEDRTD011247PregnancyDISEASEci_withdihydroergocryptine
MEDRTD011618Psychotic DisordersDISEASEci_withdihydroergocryptine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moadihydroergocryptine
MEDRTN0000000117Dopamine AgonistsMOAhas_moadihydroergocryptine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moadihydroergocryptine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_pedihydroergocryptine
MEDRTN0000008376Cutaneous Arterial VasoconstrictionPEhas_pedihydroergocryptine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI